It targets MYC and THBS1, which participate in the cell cycle, Wnt signaling route, and p53 signaling pathway, among many other pathways, that matched with Geraldo et al. (85), who identified that the miR-487-3p could act as a tumor suppressor. The gene discussed is TP53; the disease is neoplasm.